Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
OS Fund
AddedFeb 13, 2024
UpdatedJul 16, 2026
OS Fund

OS Fund

Operating

OS Fund LLC: A U.S. venture capital firm investing in seed and early-stage businesses.

Location
Chicago, IL, US
Founded
2014
Firm
Compare
Portfolio
Employees
Website

Investments

Arzeda
Arzeda

Total Raised

$66.4M

Rounds

11

Series B$33MMarch 2022
Series A$12MJuly 2017
A-Alpha Bio
A-Alpha Bio

Total Raised

$49.6M

Rounds

8

Seed$2.8MSeptember 2019
GRO Biosciences
GRO Biosciences

Total Raised

$32.3M

Rounds

6

Seed$3.5MMarch 2019
Seed$2.4MFebruary 2018
Lygos
Lygos

Total Raised

$211.5M

Rounds

14

Series B$15.5MJuly 2018
Series A$13MDecember 2016
Verge Genomics
Verge Genomics

Total Raised

$134.1M

Rounds

4

Series A$32MJuly 2018
Seed$4MOctober 2015
Catalog
Catalog

Total Raised

$54.3M

Rounds

6

Seed$4MJune 2018
Seed$5MJuly 2017
NuMat Technologies
NuMat Technologies

Total Raised

$23.7M

Rounds

6

Series B$12.4MApril 2018
Series A$7MAugust 2016
Aria Pharmaceuticals
Aria Pharmaceuticals

Total Raised

$14.3M

Rounds

4

Series A$10MMarch 2018
3T Biosciences
3T Biosciences

Total Raised

$52M

Rounds

3

Seed$12MOctober 2017
Synthego
Synthego

Total Raised

$460.5M

Rounds

9

Series B$41MJanuary 2017
Prospect Bio
Prospect Bio

Total Raised

$2.8M

Rounds

2

Seed$2.8MNovember 2016
Emulate
Emulate

Total Raised

$224.3M

Rounds

9

Series B$17MOctober 2016
Series B$28MMarch 2016
Elysium Health
Elysium Health

Total Raised

$71.2M

Rounds

8

Series AJune 2016
Human Longevity
Human Longevity
Acquired

Total Raised

$340.5M

Rounds

5

Series B$220MApril 2016
Pivot Bio
Pivot Bio

Total Raised

$616.9M

Rounds

7

Series A$16MMarch 2016
Lucira Health
Lucira Health
Public

Total Raised

$147.3M

Rounds

11

Series A$13.1MOctober 2015
Ginkgo Bioworks
Ginkgo Bioworks
Public

Total Raised

$1.6B

Rounds

17

Series B$53.3MJuly 2015
Emerald Cloud Lab
Emerald Cloud Lab

Total Raised

$92.1M

Rounds

6

Series Unknown$20.6MJune 2015